An in-depth look to AC IMMUNE SA SF-,02 operating, investing, and financing activities

IMR free cash flow for Q1 25 is -19.72 M EUR. For 2024, IMR free cash flow was 71.59 M EUR and operating cash flow was 72.22 M EUR.